Navigation Links
Synedgen's Synoplex® is Headed to the Lewa Wildlife Conservancy in Kenya
Date:8/6/2013

Claremont, CA (PRWEB) August 06, 2013

Synedgen is donating a supply of its veterinary wound rinse product Synoplex®, designed to treat infected, chronic and non-infected wounds in elephants and rhinoceros, to the Lewa Wildlife Conservancy. The donation is in honor of the late Anna Merz, a world champion of black rhinoceroses and animal conservation, who helped start Lewa in response to the poaching and slaughter of rhinoceroses.

“Synedgen applauds the efforts of the Lewa Conservancy, and would like to contribute to the legacy of Anna Merz. We hope Lewa will find Synoplex to be helpful in their efforts to treat wounds and improve healing not only in rhinos, but other pachyderms in the Conservancy,” stated Synedgen president Shenda Baker.

“This donation marks the first use of Synoplex in the wild, and we are proud to support Lewa’s conservation effort,” added Synedgen CEO William Wiesmann. “We are particularly pleased that the active ingredients in Synoplex are biodegradable and will not harm the environment.”

Founded in 1995, the Lewa Wildlife Conservancy (http://www.lewa.org) spans 61,000 acres and serves as catalyst for conservation across northern Kenya. Lewa holds 11% of Kenya’s black rhino population and 20% of the world’s Grevy’s zebras. Through the protection and management of endangered species, the initiation and support of community conservation and development programs, and the education of neighboring communities in the value of wildlife, Lewa has become a model in Kenya for wildlife conservation on private land, a favored destination for low impact tourism, and a leading catalyst for development centric conservation in northern Kenya. The Conservancy is also home to the Northern Rangelands Trust, an innovative community conservation partnership where upwards of 25 communities, spanning over three million acres of land to the north of Lewa, have embraced wildlife conservation as part of their vision for development of the people and land on which they live.

Lewa Executive Director Ginger Thomson stated, “We are grateful to Synedgen for providing our hard-working team at Lewa, led by Matthew Matunda of the Kenya Wildlife Service, an opportunity to use Synoplex with our rhinoceroses. We currently have more than 130 rhino within the Conservancy's fences, and we work with several other conservancies on rhino conservation, leading efforts to bring the newest technologies and science to preserve this iconic animal in the wild. As an experienced wildlife vet, Matunda was thrilled to be one of the first to use Synoplex directly in the field.”

Synoplex is legally marketed as an FDA Indexed Product under MIF 900-012, and is available directly from Synedgen.

About Synedgen
Synedgen Inc. is an innovative biopharmaceutical company focused on developing novel therapies and products through its proprietary biomaterials technology platform. Product development is targeted to specifically address unmet needs for therapies to treat inflammation, damage or infection at dermal, pulmonary and gastrointestinal surfaces. Synedgen’s Corporate Headquarters, Research Laboratories and Manufacturing Facility are in Claremont CA. Additional information can be found at Synedgen’s web site at http://www.synedgen.com.

Read the full story at http://www.prweb.com/releases/2013/8/prweb10999306.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Synedgen’s Synoplex® Receives FDA Indexing for Use in the Treatment of Chronic Wounds in Pachyderms
2. Prolongs Large Scale Manufacturing of Sickle Cell Product to be Headed by Industry Veteran
3. Are Root Canals Headed for Obscurity? Stem Cell Study Indicates Maybe So
4. Elsevier Launches International Journal for Parasitology: Parasites and Wildlife
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the "Company") (TSX-V: SQD; ... three months ended December 31, 2016. SQI ... diagnostics company that develops and commercializes proprietary technologies and products ... ... commercial milestones achieved in fiscal 2016," said Andrew Morris ...
(Date:2/21/2017)... ... ... The medical potential of stem cells is both extensive and astounding, and ... their differentiating characteristics. Stem cells are unique as the have the potential to renew ... tissue or organic-specific cells with special functions. , Stem cell therapy in the ...
(Date:2/21/2017)... 21, 2017  Lexus, a returning partner of the Amgen ... and exclusive automobile partner of the men,s and women,s events for ... The 2017 Amgen Tour of California will ... of the best professional cycling teams in the world racing from ... four-day Amgen Breakaway from Heart Disease TM Women,s ...
(Date:2/20/2017)... (PRWEB) , ... February 20, 2017 , ... ... to announce that it has been approved for full, active membership in the ... Dallas, Texas, was founded by Chief Executive Officer Jeff Olson in ...
Breaking Biology Technology:
(Date:2/13/2017)... , Feb. 13, 2017 Former 9/11 Commission ... Judiciary Committee, Janice Kephart of Identity Strategy ... Donald Trump,s "Executive Order: Protecting the Nation ... 27, 2017):  "As President Trump,s ,Travel Ban, ... has now essentially banned the travel ban, it is ...
(Date:2/8/2017)... , Feb. 7, 2017 Report Highlights ... The global synthetic-biology ... $11.4 billion by 2021, growing at a compound annual growth ... An overview of the global markets for synthetic biology. - ... for 2016, and projections of compound annual growth rates (CAGRs) ...
(Date:2/7/2017)... 7, 2017 Ipsidy Inc. ( ... [OTC: IDGS], ("Ipsidy" or the "Company") a provider of ... services, is pleased to announce the following changes as ... Effective January 31, 2017, Philip D. Beck ... and President.  An experienced payment industry professional and public ...
Breaking Biology News(10 mins):